Statistical analysis
Statistical analysis was performed using GraphPad Prism. Data are expressed as mean ± standard deviation (SD). Statistical significance was tested for multiple comparisons with analysis of variance (ANOVA). The differences were considered to be significant if p<0.05.
Production of lentiviral particles and transduction of cells
Third generation lentiviral packaging plasmids and vectors containing shRNA (scrambled (scri) or targeted against furin (target sequence shFAi: CCTGTCCCTCTAAAGCAATAA; target sequence shFEi: CCACATGACTACTCCGCAGAT)) under a U6-tet promoter as well as reporter genes GFP and puromycine resistance under PGK promoter were purchased from Cellecta (Cellecta Inc. Mountain View, USA). Lentiviral particles were generated by calcium phosphate-based transfection of HEK293T cells. Transducing units per mL (TU/mL) were determined through titration of lentiviral particles on Rh4 cells and analysis of % GFP positive cells by fluorescent activated cell sorting (FACS) on a FACSCanto II (BD Bioscience, Missisagua, Canada) 48h post transduction. TU/mL were determined using the formula TU/mL= (F*C*D)/V (F=frequency of GFP positive cells; C=number of cells; D=virus dilution; V=volume of inoculum). Cells were transduced with a multiplicity of infection (MOI) of 5. Transduction was performed by addition of required amount of lentiviral particles in DMEM in the presence of 10 µg/mL polybrene (Sigma-Aldrich) followed by centrifugation (32 °C, 1h, 800 g). Medium was replaced with fresh medium 4h post transduction start and efficiency of transduction was determined by analysis of GFP-positive cells by FACS 7-10 days post transduction. Transduction efficiency was over 98% for all cell lines.
To generate Rh4 cells with double knock out for BAX and BAK a CRISPR/Cas9-based approach was chosen. Vectors based on the LentiCrispr v1 vector (Addgene) were modified to carry a TagBFP for selection and delivered packaged in lentiviral particles. Two different sgRNAs for each target gene were evaluated individually for their knock down efficiency by Western blot and the two best sequences were then co-delivered to achieve a double knock out (Rh4 BAX/BAK; sgRNA BAX: CGAGTGTCTCAAGCGCATCG; sgRNA BAK: ACGGCAGCTCGCCATCATCG). A scrambled sgRNA sequence was used as control (Rh4 sc; sgRNA sc: GCACTACCAGAGCTAACTCA).
Antibodies
The following antibodies were used: furin MON-152 (1:750, ALX-803-017-R100, Alexis Corporation), anti-IGF1Rβ (9750S, Cell Signaling), anti-caspase-9 (9502, Cell Signaling), anti-cleaved caspase-7 (9491, Cell Signaling), anti-PARP (9542, Cell Signaling), anti-Akt (9272, Cell Signaling), anti-phospho-Akt (Ser437, 9018, Cell Signaling), anti-Erk1/2 (9102, Cell Signaling), antiphospho-Erk1/2 (4370, Cell Signaling) and anti-α-tubulin (1:5000, A5316, Sigma-Aldrich). All Cell Signaling antibodies were used in a dilution of 1:1000. ng/mL DOX for 72h in the presence or absence of 100 µM zVAD. A. Cell viability was examined in a WST-1 assay. B. The number of cells was analyzed by staining with crystal violet. Data represent mean ±SD of three independent experiments. *P<0.05, **P<0.01, ***P<0.005, two-way ANOVA.
